CS logo
small CS logo
CH Pierre Bérégovoy

Nevers, France

About CH Pierre Bérégovoy


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Federation Francophone de Cancerologie Digestive
3
University Hospital, Bordeaux
3
Biotronik SE & Co. KG
1
Centre Hospitalier Universitaire Dijon
1
Total Rows: 4

Clinical Trials at CH Pierre Bérégovoy


During the past decade, CH Pierre Bérégovoy conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years220000001111000000000000Started TrialsCompleted Trails2016201720182019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
2003-06-01
2011-01-01
Completed
282
Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia
2007-06-01
2011-12-01
Completed
100
Multicenter Trial Estimating the Persistence of Molecular Remission in Chronic Myeloid Leukaemia in Long Term After Stopping Imatinib
2011-04-06
2017-05-30
Completed
220
Assessment of Intracardiac Electrograms Transmitted by Home Monitoring for the Remote Follow-up of Pacemaker (PREMS)
2014-07-01
2015-12-01
Completed
571
Surgery, Tissue Plasminogen Activator, Antiangiogenic Agents and Age Related Macular Degeneration Complications
2016-04-28
Completed
91
PHASE III RANDOMISED TRIAL TO EVALUATE FOLFOX WITH OR WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY FOR LOCALLY ADVANCED OR METASTATIC OESOPHAGO-GASTRIC CARCINOMA
2016-12-01
2022-12-01
Recruiting
506
The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients
2020-04-03
2021-09-30
Completed
1,523
Prognostic Determinants in Patients With Diabetic Foot Ulcer.
2021-07-01
2029-07-01
Not yet recruiting
1,000

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "CH Pierre Bérégovoy" #1 collaborator was "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Association de Neuro-Oncologues d'Expression Francaise" with 1 trials as a collaborator, "Fondation Francophone pour la Recherche sur le Diabete" with 1 trials as a collaborator and "GORTEC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.
Created with Highcharts 11.1.0Top Leading SponsorsFederation Francophonede CancerologieDigestive: 3Federation Francophonede CancerologieDigestive: 3University Hospital, Bordeaux: 3University Hospital, Bordeaux: 3Biotronik SE & Co. KG: 1Biotronik SE & Co. KG: 1Centre HospitalierUniversitaire Dijon: 1Centre HospitalierUniversitaire Dijon: 1

Created with Highcharts 11.1.0Top CollaboratorsGERCOR -MultidisciplinaryOncology CooperativeGroup: 2GERCOR -MultidisciplinaryOncology CooperativeGroup: 2ARCAGY/ GINECO GROUP: 1ARCAGY/ GINECO GROUP: 1Association de Neuro-Oncologuesd'Expression Francaise:1Association de Neuro-Oncologuesd'Expression Francaise:1Fondation Francophonepour la Recherche surle Diabete: 1Fondation Francophonepour la Recherche surle Diabete: 1GORTEC: 1GORTEC: 1IntergroupeFrancophone deCancerologieThoracique: 1IntergroupeFrancophone deCancerologieThoracique: 1UNICANCER: 1UNICANCER: 1

Clinical Trials Conditions at CH Pierre Bérégovoy


According to Clinical.Site data, the most researched conditions in "CH Pierre Bérégovoy" are "Bradycardia" (1 trials), "COVID" (1 trials), "Cancer" (1 trials), "Chemotherapy" (1 trials) and "Chronic Myeloid Leukaemia" (1 trials). Many other conditions were trialed in "CH Pierre Bérégovoy" in a lesser frequency.

Clinical Trials Intervention Types at CH Pierre Bérégovoy


Most popular intervention types in "CH Pierre Bérégovoy" are "Drug" (3 trials), "Behavioral" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "5Fluorouracil bolus" (1 trials), "5Fluorouracil continu" (1 trials), "Docetaxel" (1 trials), "Folinic Acid" (1 trials) and "Imatinib ending" (1 trials). Other intervention names were less common.

Clinical Trials Genders at CH Pierre Bérégovoy


The vast majority of trials in "CH Pierre Bérégovoy" are 8 trials for "All" genders.

Clinical Trials Status at CH Pierre Bérégovoy


Currently, there are NaN active trials in "CH Pierre Bérégovoy". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in CH Pierre Bérégovoy, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CH Pierre Bérégovoy, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhaseNot Applicable: 3Not Applicable: 3Phase 3: 2Phase 3: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 6Completed: 6Not yet recruiting: 1Not yet recruiting: 1Recruiting: 1Recruiting: 1